Psilocybin / Magic Mushrooms

Signature-gathering for 2020 is about to get underway.

The Michigan marijuana initiative still has a healthy lead as Election Day nears, the FDA has granted "breakthrough therapy" status for psilocybin for treatment-resistant depression, and more.

Jerry Brown signs and vetoes drug bills, the drug czar's office confirms the existence of a secretive marijuana committee, Johns Hopkins researchers suggest psilocybin should be Schedule IV, and more.

Next year, the Mile High City could get even higher.

New polls show strong support for marijuana legalization in Michigan and New Jersey, the Manhattan DA throws out 3,000 pot cases, Denver mushroom activists are pushing a new initiative, and more.

New polls in New Jersey and Wisconsin show solid support for marijuana legalization, Chicago harm reduction pioneer Dan Big has died too early, the FDA approves clinical trials of psilocybin for treatment-resistant depression, an Ohio drug defelonization initiative is on the November ballot, and more.

These powerful substances are making their way into the heart of the psychology establishment and starting to be understood as powerful therapeutic tools.

In a surprise move, New Jersey's attorney general suspends marijuana prosecutions, an Oklahoma marijuana trade group releases proposed draft medical marijuana regulations, a Denver initiative to decriminalize magic mushrooms is delayed, and more.

A clinical trial underway right now hopes to find the answer -- and more participants.

This helps explain why they are increasingly seen as a valuable treatment for psychiatric disorders such as depression, anxiety, and addiction.